Regulatory Compliance under the UKCA and MHRA Frameworks
Following the post-Brexit transition, the Medicines and Healthcare products Regulatory Agency (MHRA) has established a robust UKCA marking system specifically for "Custom-Made Devices."
In 2026, the UK regulatory environment is noted for its "Quality Management Systems" (QMS) requirements for hospitals that print on-site. The MHRA requires strict validation of the metal powders used and the "clean-room" environments where the printers reside. This ensures that a 3D-printed jawbone or spinal cage produced in a hospital lab meets the exact same safety standards as a mass-produced device from a global factory, providing a safe legal framework for surgical innovation.
2 Views